Skip to main content
Clinical Trials/TCTR20221031001
TCTR20221031001
Completed
Not Applicable

Prevalence and clinicopathological characteristics of programmed death-ligand 1 expression in Thai patients with gastric cancer

Faculty of Medicine, Chiang Mai University0 sites268 target enrollmentOctober 31, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
The primary objective is to investigate the correlation between PD-L1 expression and gastric cancer staging according to American Joint Committee on Cancer (AJCC) TNM staging, eighth edition. The secondary objectives are to investigate the correlation between PD-L1 expression and other clinicopathological characteristics and overall survival.
Sponsor
Faculty of Medicine, Chiang Mai University
Enrollment
268
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 31, 2022
End Date
December 31, 2021
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\.Tissue samples from patients who had newly diagnosed gastric cancer and underwent either biopsy or surgical treatment in the Maharaj Nakorn Chiang Mai hospital from January 1, 2018, to December 31, 2021
  • 2\.Age more than 18 years old.
  • 3\.Tissue sample was available to assess PD\-L1 expression by immunohistochemistry technique.

Exclusion Criteria

  • 1\.No recorded hospital admission or follow\-up data in Maharaj Nakorn Chiang Mai hospital electronic medical record.
  • 2\.Diagnosed other types of malignancy (Gastrointestinal stromal tumor, Lymphoma, Neuroendocrine tumor, or Metastatic tumor).
  • 3\.Have other active malignancies or during chemotherapy or radiation for other malignancies.

Outcomes

Primary Outcomes

Not specified

Similar Trials